This kit is based on the double-antibody sandwich method and is used for the quantitative measurement of T7 RNA polymerase in mRNA drugs. It assists in evaluating the quality of mRNA drugs during drug development and CMC (Chemistry, Manufacturing, and Controls) quality control. The T7 enzyme(P/N: BP-E01)
developed by Biori features low dsRNA by-product levels in mRNA raw material and can be used with this kit for highly sensitive detection of T7 RNA polymerase in transcription-purified samples.
Product Features:
1. Specificity: No cross-reactivity with DNase I, RNA inhibitors, etc.
2. Sensitivity: Detection limit as low as 0.2 ng/mL.
3. Reproducibility: Intra- and inter-assay precision CV within 15%.
4. Accuracy: Spiked sample recovery rate of 80% to 120%.
5. Versatility: Suitable for the quantitative detection of T7 enzymes from multiple brands.
+86-756-8699969
Addr.: #333, Pingbei First Road, Nanping Industrial Park, Zhuhai, China 519000
Email:marketing@biori.com